PMC:7346000 / 31903-32126 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T64","span":{"begin":132,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A64","pred":"fma_id","subj":"T64","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"Country (Prevalence) COHORT [Ref] Age/Sex Underlying Conditions CAPA Classification Local/Systemic Corticosteroid Use GM (ODI)/Serum BDG (pg/mL)/qPCR Species (Voriconazole Susceptibility Pattern) Treatment # Outcome"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T34","span":{"begin":132,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"uberon_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Country (Prevalence) COHORT [Ref] Age/Sex Underlying Conditions CAPA Classification Local/Systemic Corticosteroid Use GM (ODI)/Serum BDG (pg/mL)/qPCR Species (Voriconazole Susceptibility Pattern) Treatment # Outcome"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T245","span":{"begin":67,"end":71},"obj":"Disease"}],"attributes":[{"id":"A245","pred":"mondo_id","subj":"T245","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"}],"text":"Country (Prevalence) COHORT [Ref] Age/Sex Underlying Conditions CAPA Classification Local/Systemic Corticosteroid Use GM (ODI)/Serum BDG (pg/mL)/qPCR Species (Voriconazole Susceptibility Pattern) Treatment # Outcome"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T236","span":{"begin":143,"end":145},"obj":"http://purl.obolibrary.org/obo/CLO_0008426"}],"text":"Country (Prevalence) COHORT [Ref] Age/Sex Underlying Conditions CAPA Classification Local/Systemic Corticosteroid Use GM (ODI)/Serum BDG (pg/mL)/qPCR Species (Voriconazole Susceptibility Pattern) Treatment # Outcome"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T209","span":{"begin":123,"end":125},"obj":"Chemical"}],"attributes":[{"id":"A209","pred":"chebi_id","subj":"T209","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"}],"text":"Country (Prevalence) COHORT [Ref] Age/Sex Underlying Conditions CAPA Classification Local/Systemic Corticosteroid Use GM (ODI)/Serum BDG (pg/mL)/qPCR Species (Voriconazole Susceptibility Pattern) Treatment # Outcome"}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T12","span":{"begin":123,"end":125},"obj":"GlycoEpitope"}],"attributes":[{"id":"A12","pred":"glyco_epitope_db_id","subj":"T12","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"Country (Prevalence) COHORT [Ref] Age/Sex Underlying Conditions CAPA Classification Local/Systemic Corticosteroid Use GM (ODI)/Serum BDG (pg/mL)/qPCR Species (Voriconazole Susceptibility Pattern) Treatment # Outcome"}

{"project":"LitCovid-sentences","denotations":[{"id":"T174","span":{"begin":0,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Country (Prevalence) COHORT [Ref] Age/Sex Underlying Conditions CAPA Classification Local/Systemic Corticosteroid Use GM (ODI)/Serum BDG (pg/mL)/qPCR Species (Voriconazole Susceptibility Pattern) Treatment # Outcome"}